PL2294072T3 - Triazine compounds as p13 kinase and mtor inhibitors - Google Patents

Triazine compounds as p13 kinase and mtor inhibitors

Info

Publication number
PL2294072T3
PL2294072T3 PL09751541T PL09751541T PL2294072T3 PL 2294072 T3 PL2294072 T3 PL 2294072T3 PL 09751541 T PL09751541 T PL 09751541T PL 09751541 T PL09751541 T PL 09751541T PL 2294072 T3 PL2294072 T3 PL 2294072T3
Authority
PL
Poland
Prior art keywords
kinase
mtor inhibitors
triazine compounds
triazine
mtor
Prior art date
Application number
PL09751541T
Other languages
Polish (pl)
Inventor
Aranapakam M. Venkatesan
Zecheng Chen
Christoph M. Dehnhardt
Santos Osvaldo Dos
Santos Efren Guillermo Delos
Arie Zask
Jeroen C. Verheijen
Joshua Aaron Kaplan
David J. Richard
Semiramis Ayral-Kaloustian
Tarek S. Mansour
Ariamala Gopalsamy
Kevin J. Curran
Mengxiao Shi
Original Assignee
Wyeth Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Llc filed Critical Wyeth Llc
Priority claimed from EP09751541.5A external-priority patent/EP2294072B1/en
Publication of PL2294072T3 publication Critical patent/PL2294072T3/en

Links

PL09751541T 2008-05-23 2009-05-21 Triazine compounds as p13 kinase and mtor inhibitors PL2294072T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5566108A 2008-05-23 2008-05-23
EP09751541.5A EP2294072B1 (en) 2008-05-23 2009-05-21 Triazine compounds as p13 kinase and mtor inhibitors

Publications (1)

Publication Number Publication Date
PL2294072T3 true PL2294072T3 (en) 2017-08-31

Family

ID=59724520

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09751541T PL2294072T3 (en) 2008-05-23 2009-05-21 Triazine compounds as p13 kinase and mtor inhibitors

Country Status (2)

Country Link
HU (1) HUE032157T2 (en)
PL (1) PL2294072T3 (en)

Also Published As

Publication number Publication date
HUE032157T2 (en) 2017-09-28

Similar Documents

Publication Publication Date Title
HRP20190680T1 (en) Triazine compounds as p13 kinase and mtor inhibitors
IL206358A0 (en) Pyrrolopyrazine kinase inhibitors
IL206818A0 (en) Pyrrolopyrazine kinase inhibitors
EP2150255A4 (en) Quinoxaline derivatives as p13 kinase inhibitors
HRP20130787T1 (en) Imidazopyridazinecarbonitriles useful as kinase inhibitors
ZA200907777B (en) Quinoline derivatives as P13 kinase inhibitors
EP2346508A4 (en) Heterocyclic kinase inhibitors
HRP20130698T1 (en) Novel phenylpyrazinones as kinase inhibitors
EP2046333A4 (en) Thiozolidinedione derivatives as p13 kinase inhibitors
EP2382207A4 (en) Pi3k/mtor kinase inhibitors
IL213464A0 (en) Kinase inhibitor compounds
IL210573A0 (en) Compounds as kinase inhibitors
EP2365809A4 (en) Pyrazinopyrazines and derivatives as kinase inhibitors
EP2231152A4 (en) Thienopyranones as kinase inhibitors
HK1156611A1 (en) Naphthyridininones as aurora kinase inhibitors aurora
GB0608854D0 (en) P13 kinase inhibitors
PL2294072T3 (en) Triazine compounds as p13 kinase and mtor inhibitors
ZA201004903B (en) Pyrrolopyrazine kinase inhibitors